PortfoliosLab logo
SRPT vs. ML
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SRPT and ML is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

SRPT vs. ML - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sarepta Therapeutics, Inc. (SRPT) and MoneyLion Inc. (ML). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

SRPT:

$3.58B

ML:

$972.40M

EPS

SRPT:

-$2.64

ML:

$0.76

PS Ratio

SRPT:

1.60

ML:

1.78

PB Ratio

SRPT:

3.13

ML:

3.34

Total Revenue (TTM)

SRPT:

$2.23B

ML:

$424.90M

Gross Profit (TTM)

SRPT:

$1.81B

ML:

$356.78M

EBITDA (TTM)

SRPT:

-$117.73M

ML:

$37.39M

Returns By Period


SRPT

YTD

-68.80%

1M

-29.47%

6M

-63.75%

1Y

-71.12%

3Y*

-18.90%

5Y*

-24.05%

10Y*

3.76%

ML

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Sarepta Therapeutics, Inc.

MoneyLion Inc.

Risk-Adjusted Performance

SRPT vs. ML — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRPT
The Risk-Adjusted Performance Rank of SRPT is 22
Overall Rank
The Sharpe Ratio Rank of SRPT is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of SRPT is 33
Sortino Ratio Rank
The Omega Ratio Rank of SRPT is 22
Omega Ratio Rank
The Calmar Ratio Rank of SRPT is 33
Calmar Ratio Rank
The Martin Ratio Rank of SRPT is 00
Martin Ratio Rank

ML
The Risk-Adjusted Performance Rank of ML is 6262
Overall Rank
The Sharpe Ratio Rank of ML is 6060
Sharpe Ratio Rank
The Sortino Ratio Rank of ML is 6464
Sortino Ratio Rank
The Omega Ratio Rank of ML is 6565
Omega Ratio Rank
The Calmar Ratio Rank of ML is 6262
Calmar Ratio Rank
The Martin Ratio Rank of ML is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SRPT vs. ML - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and MoneyLion Inc. (ML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

SRPT vs. ML - Dividend Comparison

Neither SRPT nor ML has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SRPT vs. ML - Drawdown Comparison


Loading data...

Volatility

SRPT vs. ML - Volatility Comparison


Loading data...

Financials

SRPT vs. ML - Financials Comparison

This section allows you to compare key financial metrics between Sarepta Therapeutics, Inc. and MoneyLion Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20212022202320242025
744.86M
158.59M
(SRPT) Total Revenue
(ML) Total Revenue
Values in USD except per share items